Valneva announces extension of the interest-only period of its debt facility with deerfield and orbimed

Saint-herblain (france), march 18, 2024 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announced an agreement with funds managed by leading u.s. healthcare investment firms deerfield management company and orbimed to extend the interest-only period of its existing loan by eighteen months.
VALN Ratings Summary
VALN Quant Ranking